88 related articles for article (PubMed ID: 21226332)
1. [Structure and function of marinostatin, a serine protease inhibitor].
Taichi M; Nishiuchi Y
Seikagaku; 2010 Nov; 82(11):1032-6. PubMed ID: 21226332
[No Abstract] [Full Text] [Related]
2. Solution structure of marinostatin, a natural ester-linked protein protease inhibitor.
Kanaori K; Kamei K; Taniguchi M; Koyama T; Yasui T; Takano R; Imada C; Tajima K; Hara S
Biochemistry; 2005 Feb; 44(7):2462-8. PubMed ID: 15709758
[TBL] [Abstract][Full Text] [Related]
3. Relationship between temporary inhibition and structure of disulfide-linkage analogs of marinostatin, a natural ester-linked protein protease inhibitor.
Taniguchi M; Kamei K; Kanaori K; Koyama T; Yasui T; Takano R; Harada S; Tajima K; Imada C; Hara S
J Pept Res; 2005 Aug; 66(2):49-58. PubMed ID: 16000118
[TBL] [Abstract][Full Text] [Related]
4. Cloning and nucleotide sequence of the gene encoding a serine proteinase inhibitor named marinostatin from a marine bacterium, Alteromonas sp. strain B-10-31.
Miyamoto K; Tsujibo H; Hikita Y; Tanaka K; Miyamoto S; Hishimoto M; Imada C; Kamei K; Hara S; Inamori Y
Biosci Biotechnol Biochem; 1998 Dec; 62(12):2446-9. PubMed ID: 9972273
[TBL] [Abstract][Full Text] [Related]
5. Role of the backbone conformation at position 7 in the structure and activity of marinostatin, an ester-linked serine protease inhibitor.
Taichi M; Yamazaki T; Nishiuchi Y
Chembiochem; 2012 Sep; 13(13):1895-8. PubMed ID: 22851252
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of marinostatin, a serine protease inhibitor isolated from a marine organism.
Taichi M; Yamazaki T; Kawahara K; Motooka D; Nakamura S; Harada S; Teshima T; Ohkubo T; Kobayashi Y; Nishiuchi Y
J Pept Sci; 2010 Jul; 16(7):329-36. PubMed ID: 20552565
[TBL] [Abstract][Full Text] [Related]
7. [XYZ of ABC proteins?: where is the goal for the study of ABC protein structure?].
Matsuo M; Ueda K
Tanpakushitsu Kakusan Koso; 2002 Sep; 47(11):1431-8. PubMed ID: 12229211
[No Abstract] [Full Text] [Related]
8. A novel two-chain proteinase inhibitor generated by circularization of a multidomain precursor protein.
Lee MC; Scanlon MJ; Craik DJ; Anderson MA
Nat Struct Biol; 1999 Jun; 6(6):526-30. PubMed ID: 10360353
[TBL] [Abstract][Full Text] [Related]
9. The role of scaffolding in standard mechanism serine proteinase inhibitors.
Kelly CA; Laskowski M; Qasim MA
Protein Pept Lett; 2005 Jul; 12(5):465-71. PubMed ID: 16029159
[TBL] [Abstract][Full Text] [Related]
10. The structures of MsbA: Insight into ABC transporter-mediated multidrug efflux.
Reyes CL; Ward A; Yu J; Chang G
FEBS Lett; 2006 Feb; 580(4):1042-8. PubMed ID: 16337944
[TBL] [Abstract][Full Text] [Related]
11. Ecotin: lessons on survival in a protease-filled world.
McGrath ME; Gillmor SA; Fletterick RJ
Protein Sci; 1995 Feb; 4(2):141-8. PubMed ID: 7757004
[TBL] [Abstract][Full Text] [Related]
12. Discovery of inhibitors of the channel-activating protease prostasin (CAP1/PRSS8) utilizing structure-based design.
Tully DC; Vidal A; Chatterjee AK; Williams JA; Roberts MJ; Petrassi HM; Spraggon G; Bursulaya B; Pacoma R; Shipway A; Schumacher AM; Danahay H; Harris JL
Bioorg Med Chem Lett; 2008 Nov; 18(22):5895-9. PubMed ID: 18752942
[TBL] [Abstract][Full Text] [Related]
13. Unraveling sub-site specificities of peptidic serine protease inhibitors by substitutional and structural analysis.
Höhne W; Hilpert K
Protein Pept Lett; 2005 Jul; 12(5):449-56. PubMed ID: 16029157
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity studies of cyclic ketone inhibitors of the serine protease plasmin: design, synthesis, and biological activity.
Xue F; Seto CT
Bioorg Med Chem; 2006 Dec; 14(24):8467-87. PubMed ID: 16971130
[TBL] [Abstract][Full Text] [Related]
15. How to really heal with crystals.
Nat Struct Biol; 1996 Jun; 3(6):483-4. PubMed ID: 8646527
[No Abstract] [Full Text] [Related]
16. Serine protease inhibitors (SERPINS): where mechanism meets medicine.
Rubin H
Nat Med; 1996 Jun; 2(6):632-3. PubMed ID: 8640547
[No Abstract] [Full Text] [Related]
17. Structure-based design of a novel series of azetidine inhibitors of the hepatitis C virus NS3/4A serine protease.
Parsy C; Alexandre FR; Brandt G; Caillet C; Cappelle S; Chaves D; Convard T; Derock M; Gloux D; Griffon Y; Lallos L; Leroy F; Liuzzi M; Loi AG; Moulat L; Musiu C; Rahali H; Roques V; Seifer M; Standring D; Surleraux D
Bioorg Med Chem Lett; 2014 Sep; 24(18):4444-4449. PubMed ID: 25155387
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the human GINS complex.
Choi JM; Lim HS; Kim JJ; Song OK; Cho Y
Genes Dev; 2007 Jun; 21(11):1316-21. PubMed ID: 17545466
[TBL] [Abstract][Full Text] [Related]
19. [Progresses in the structure and function of Kazal-type proteinase inhibitors].
Zheng QL; Sheng Q; Zhang YZ
Sheng Wu Gong Cheng Xue Bao; 2006 Sep; 22(5):695-700. PubMed ID: 17037188
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1.
Li P; Jiang S; Lee SL; Lin CY; Johnson MD; Dickson RB; Michejda CJ; Roller PP
J Med Chem; 2007 Nov; 50(24):5976-83. PubMed ID: 17985858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
